Cargando…

Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice

BACKGROUND: Human papillomaviruses (HPV) are the causative agents of cervical cancer in women, which results in over 250 000 deaths per year. Presently there are two prophylactic vaccines on the market, protecting against the two most common high-risk HPV types 16 and 18. These vaccines remain very...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitehead, Mark, Öhlschläger, Peter, Almajhdi, Fahad N, Alloza, Leonor, Marzábal, Pablo, Meyers, Ann E, Hitzeroth, Inga I, Rybicki, Edward P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041048/ https://www.ncbi.nlm.nih.gov/pubmed/24885328 http://dx.doi.org/10.1186/1471-2407-14-367

Ejemplares similares

Optimizing a Human Papillomavirus Type 16 L1-Based Chimaeric Gene for Expression in Plants
por: Hitzeroth, Inga I., et al.
Publicado: (2018)

Design of a Highly Effective Therapeutic HPV16 E6/E7-Specific DNA Vaccine: Optimization by Different Ways of Sequence Rearrangements (Shuffling)
por: Almajhdi, Fahad N., et al.
Publicado: (2014)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

Therapeutic vaccines for high-risk HPV-associated diseases
por: Chabeda, Aleyo, et al.
Publicado: (2017)

Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants
por: Pietersen, Inge, et al.
Publicado: (2020)

Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity
por: Chabeda, Aleyo, et al.
Publicado: (2019)

Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana
por: Yanez, Romana J. R., et al.
Publicado: (2017)

LALF(32‐51)‐E7, a HPV‐16 therapeutic vaccine candidate, forms protein body‐like structures when expressed in Nicotiana benthamiana leaves
por: Yanez, Romana J. R., et al.
Publicado: (2017)

Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum
por: Kohl, Thomas O, et al.
Publicado: (2007)

African Horse Sickness: A Review of Current Understanding and Vaccine Development
por: Dennis, Susan J, et al.
Publicado: (2019)

Complete Genome Sequence of Bos taurus Papillomavirus Type 1, Isolated in Morocco
por: Regnard, Guy L., et al.
Publicado: (2017)

Complete Genome Sequences of Two Isolates of Canis familiaris Oral Papillomavirus from South Africa
por: Regnard, Guy L., et al.
Publicado: (2016)

Transient Expression and Purification of Horseradish Peroxidase C in Nicotiana benthamiana
por: Huddy, Suzanne M., et al.
Publicado: (2018)

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population
por: Marais, Dianne J, et al.
Publicado: (2006)

Immunogenicity of plant‐produced African horse sickness virus‐like particles: implications for a novel vaccine
por: Dennis, Susan J., et al.
Publicado: (2017)

Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells
por: Lamprecht, Renate L, et al.
Publicado: (2016)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Variants of human papillomaviruses 16 (HPV16) in Uigur women in Xinjiang, China
por: He, Hongchang, et al.
Publicado: (2016)

Human papillomavirus (HPV) 16 infection is not detected in rectal carcinoma
por: Martins, Sandra F., et al.
Publicado: (2020)

Recombinant expression of beak and feather disease virus capsid protein and assembly of virus-like particles in Nicotiana benthamiana
por: Regnard, Guy L., et al.
Publicado: (2017)

Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens
por: Lee, Sin Hang, et al.
Publicado: (2009)

Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes
por: Fontan, Christian T., et al.
Publicado: (2020)

Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study
por: Moodley, Jennifer R, et al.
Publicado: (2009)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

Human papillomavirus (HPV) insertional mutation as a dynamic & specific tumour biomarker in HPV-associated carcinoma
por: Sastre-Garau, Xavier
Publicado: (2015)

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
por: Dennis, Susan J., et al.
Publicado: (2018)

Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits
por: Meiring, Tracy L, et al.
Publicado: (2012)

Prevalence of Human Papillomavirus (HPV)-16 in Different Dental Infections in the Lebanese Population
por: Khalil, Wael, et al.
Publicado: (2023)

Antibodies against human papillomavirus type 16 (HPV-16) and conjunctival squamous cell neoplasia in Uganda
por: Waddell, K, et al.
Publicado: (2003)

Production of H5N1 Influenza Virus Matrix Protein 2 Ectodomain Protein Bodies in Tobacco Plants and in Insect Cells as a Candidate Universal Influenza Vaccine
por: Mbewana, Sandiswa, et al.
Publicado: (2015)

Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2010)

Immunogenicity of plant‐produced porcine circovirus‐like particles in mice
por: Gunter, Cornelius J., et al.
Publicado: (2019)

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013)

Can human papillomavirus (HPV) genotyping classify non-16/18 high-risk HPV infection by risk stratification?
por: Sung, Yeoun Eun, et al.
Publicado: (2016)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence
por: Namujju, Proscovia B, et al.
Publicado: (2011)

Effects of human papillomavirus (HPV) type 16 oncoproteins on the expression of involucrin in human keratinocytes
por: Gyöngyösi, Eszter, et al.
Publicado: (2012)

Analysis of Human Papillomavirus (HPV) 16 Variants Associated with Cervical Infection in Italian Women
por: Martinelli, Marianna, et al.
Publicado: (2020)

Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas
por: Govan, Vandana A, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_c9o3n6rq8hfq3gsh4ufj5pdecj